| ATMP | Advanced Therapy Medicinal Products |
| CBER | Center for Biologics Evaluation and Research |
| CDER | Center for Drug Evaluation and Research |
| ISEV | International Society for Extracellular |
| FDA | Food and Drug Administration |
| GMP | Good Manufacturing Practices |
| MSC | Mesenchymal Stem Cell |
| PMD | Pharmaceuticals and Medical Devices |
| ASRM | Act on the Safety of Regenerative Medicine |
| EMA | European Medicines Agency |
| PMDA | Pharmaceuticals and Medical Devices Agency |
| MFDS | Ministry of Food and Drug Safety |
| TFDA | Taiwan Food and Drug Administration |
| CDSCO | Central Drugs Standard Control Organization |
| ICMR | Indian Council of Medical Research |
| TGA | Therapeutic Goods Administration |
| NMPA | National Medical Products Administration |
| MHRA | Medicines and Healthcare Products Regulatory Agency |
| PHS | Public Health Service |
| IND | Investigational New Drug |
| BLA | Biologics License Application |
| CMC | Chemical, Manufacturing, and Control |
| CAT | Committee for Advanced Therapies |
| RMA | Regenerative Medicine Act |
| GTP | Good Tissue Practice |
| GCP | Good Clinical Practice |
| MISEV | Minimal Information for Studies of Extracellular Vesicles |
| EV | Extracellular Vesicles |
| MOA | Mechanism of Action |
| ICH | International Conference on Harmonization |
| CTN | Clinical Trial Notification |
| CTX | Clinical Trial Exemption |
| CTA | Clinical Trial Application |
| ICTRP | International Clinical Trials Registry Platform |